Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3346 Target Snapshot

Gag-Pro polyprotein · SINGLE PROTEIN · Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) (HTLV-1)

38Compounds
7Assays
0Approved Drugs
31.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P10274. Use UniProt P10274 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P10274 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Gag-Pro polyprotein as ChEMBL target CHEMBL3346, mapped to UniProt P10274. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Gag-Pro polyprotein
SINGLE PROTEIN · Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) (HTLV-1)
As of 2026-09-14
ChEMBL target ID
CHEMBL3346
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P10274
Gag-Pro polyprotein
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Gag-Pro polyprotein is the right protein anchor across sources, using UniProt P10274 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelGag-Pro polyprotein
UniProt AccessionP10274
Component TypeProtein
Sequence Length651 aa

Gag-Pro polyprotein

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Gag-Pro polyprotein, mapped to UniProt P10274. Sequence length is 651 aa.

Mapped IDP10274
Review nameGag-Pro polyprotein
OrganismHuman T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) (HTLV-1)
Clinical Profile

Clinical Phase Distribution

1
Phase II
Assay Mix

Activity Type Distribution

IC5027.0
KI4.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL272710 7.08 IC50 84.0 Preclinical
CHEMBL271706 7.06 IC50 88.0 Preclinical
CHEMBL272280 7.02 IC50 95.0 Preclinical
CHEMBL271878 7.0 IC50 101.0 Preclinical
CHEMBL403182 6.99 IC50 102.0 Preclinical
CHEMBL404702 6.99 IC50 103.0 Preclinical
CHEMBL403240 6.97 IC50 107.0 Preclinical
CHEMBL256022 6.95 IC50 113.0 Preclinical
CHEMBL403770 6.91 IC50 123.0 Preclinical
CHEMBL256587 6.88 IC50 131.0 Preclinical
Distribution

pChEMBL Value Distribution

1
5.0
1
5.5
2
6.0
20
6.5
4
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

7
Total Assays
28
Tested Compounds
1
Assay Types
Binding — 7 assays, 28 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 6 2 5.1
assay format 1 26 6.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine